Hypertrophic scar (HS) is a skin fibrotic disease that causes major clinically problematic symptoms.Cryptotanshinone (CT) is an important ingredient of Danshen (Salvia miltiorrhiza Bunge extract) that
Background: The hypertrophic scar (HS) is a serious fibrotic skin condition and a major clinical problem.Interleukin-10 (IL-10) has been identified as a prospective scar-improving compound based on pr
Hypertrophic scar (HS) is a serious skin fibrotic disease characterized by excessive hypercellularity proliferation and extracellular matrix (ECM) component deposition.
Coxsackie and adenovirus receptor (CAR), a cell adhesion molecule of the immunoglobulin superfamily, is predominantly localized to cell-cell contacts between epithelial and endothelial cells.
Hypertrophic scarring (HS) is a serious fibrotic skin condition, there is currently no satisfactory therapy to treat the disease, largely due to the undefined molecular mechanism.
Hypertrophic scar (HS) is characterized by the overgrowth of fibroblasts and often considered as a kind of benign skin tumor, thus chemotherapeutic drugs have been used to treat HS.
The coxsackie and adenovirus receptor (CAR) is a cell adhesion molecule belonging to the immunoglobulin superfamily and is predominantly localized to cell-cell contacts between epithelial and endothel
Introduction Many burn injury patients, claiming the history of psychiatric disorders, do not meet sufficient mental health care.These problems are more serious in China, which is a developing country
Background: Although burn injury remains one of the most devastating ordeals for the human being, little has been reported on the individual patients perception about the burn experience in the Chines
Purpose:Multipotent mesenchymal stromal cells, often labeled mesenchymal stem cells (MSCs) are considered a highly promising candidate cell type for cell-based tissue engineering and regeneration beca